Molecular mr imaging of prostate cancer
Kader A, Brangsch J, Kaufmann JO, Zhao J, Mangarova DB, Moeckel J, Adams LC, Sack I, Taupitz M, Hamm B, Makowski MR (2021)
Publication Type: Journal article, Review article
Publication year: 2021
Journal
Book Volume: 9
Pages Range: 1-17
Article Number: 1
Journal Issue: 1
DOI: 10.3390/biomedicines9010001
Abstract
This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.
Involved external institutions
Germany (DE)How to cite
APA:
Kader, A., Brangsch, J., Kaufmann, J.O., Zhao, J., Mangarova, D.B., Moeckel, J.,... Makowski, M.R. (2021). Molecular mr imaging of prostate cancer. Biomedicines, 9(1), 1-17. https://doi.org/10.3390/biomedicines9010001
MLA:
Kader, Avan, et al. "Molecular mr imaging of prostate cancer." Biomedicines 9.1 (2021): 1-17.
BibTeX: Download